Report Overview

The Australia Rotavirus Vaccines market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Rotavirus infection was the most common cause of severe gastroenteritis in infants and young children. Rotavirus infection can cause severe viral gastroenteritis in infants and children. Before vaccination became available in Australia, rotavirus caused up to half of all hospitalized cases of gastroenteritis in children younger than five years of age. The illness usually begins suddenly with vomiting followed by diarrhea. Rotavirus infection can result in dehydration and hospitalization. All infants <6 months of age are recommended to receive a course of oral rotavirus vaccine (Rotarix or RotaTeq). The vaccination course of Rotarix is 2 doses, at 2 and 4 months of age. The vaccination course of RotaTeq is 3 doses, at 2, 4, and 6 months of age. Infants and children can be infected with rotavirus several times during their lives. Rotavirus vaccination significantly reduces rotavirus-specific and all-cause hospital presentations for gastroenteritis.



Market Drivers

An increase in awareness regarding vaccines among patients can accelerate the growth of this market. The rise in the population of immunity-compromised individuals can act as a catalyst for market growth. An increase in the development and manufacturing of vaccines would enhance the market growth. The birth rate for Australia in 2019 was 12.720 births per 1000 people, a 1.23% decline from 2018. The birth rate for Australia in 2018 was 12.879 births per 1000 people, a 0.77% decline from 2017.

Epidemiology of ROTAVIRUS

Infection in early childhood is thought to be universal in unvaccinated children. People can be infected several times in their lives. The first infection, which typically occurs between 3 and 36 months of age, is most likely to cause severe diarrhea and dehydration.

The degree of protection after natural infection varies. After a single natural infection:

• 40% of children are protected against any subsequent infection with rotavirus.


• 75% are protected against diarrhea from subsequent rotavirus infection.


• 88% are protected against severe diarrhea caused by rotavirus.